STOCK TITAN

Kimberly-Clark Announces Major Step Forward in its Powering Care Transformation

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Kimberly-Clark (KMB) has announced a strategic partnership with Suzano (SUZ) to create a leading international tissue and professional products company. Under the agreement, Suzano will own 51% and KMB will retain 49% of the new venture, which will include KMB's International Family Care and Professional business. The contributed business generated $3.3B in net sales in 2024, with an implied enterprise value of $3.4B. The venture will encompass operations in 70+ countries, 22 manufacturing facilities, and 9,000 employees. The deal will allow KMB to focus on higher-growth personal care segments, with approximately two-thirds of future revenues coming from personal care categories. The transaction is expected to close in mid-2026 and will be $0.30-0.40 dilutive to Adjusted EPS in the first full year. Suzano will have future options to purchase KMB's remaining 49% stake.
Kimberly-Clark (KMB) ha annunciato una partnership strategica con Suzano (SUZ) per creare una società internazionale leader nel settore della carta tissue e dei prodotti professionali. Secondo l'accordo, Suzano deterrà il 51% mentre KMB manterrà il 49% della nuova joint venture, che includerà il business International Family Care e Professional di KMB. L'attività conferita ha generato 3,3 miliardi di dollari di vendite nette nel 2024, con un valore d'impresa implicito di 3,4 miliardi di dollari. La joint venture opererà in oltre 70 paesi, con 22 stabilimenti produttivi e 9.000 dipendenti. L'accordo permetterà a KMB di concentrarsi su segmenti di cura personale a più alta crescita, con circa due terzi dei ricavi futuri provenienti da categorie di cura personale. La transazione è prevista per la chiusura a metà 2026 e sarà diluitiva per l'Adjusted EPS di 0,30-0,40 dollari nel primo anno completo. Suzano avrà opzioni future per acquistare la restante quota del 49% di KMB.
Kimberly-Clark (KMB) ha anunciado una asociación estratégica con Suzano (SUZ) para crear una empresa internacional líder en productos tissue y profesionales. Según el acuerdo, Suzano poseerá el 51% y KMB conservará el 49% de la nueva empresa conjunta, que incluirá el negocio International Family Care y Professional de KMB. El negocio aportado generó 3.300 millones de dólares en ventas netas en 2024, con un valor empresarial implícito de 3.400 millones de dólares. La empresa conjunta operará en más de 70 países, con 22 instalaciones de fabricación y 9.000 empleados. El acuerdo permitirá a KMB enfocarse en segmentos de cuidado personal de mayor crecimiento, con aproximadamente dos tercios de los ingresos futuros provenientes de categorías de cuidado personal. Se espera que la transacción se cierre a mediados de 2026 y tendrá un impacto dilutivo de 0,30-0,40 dólares en el EPS ajustado en el primer año completo. Suzano tendrá opciones futuras para comprar el 49% restante de KMB.
Kimberly-Clark(KMB)는 Suzano(SUZ)와 전략적 파트너십을 발표하여 국제적인 티슈 및 전문 제품 회사 설립을 추진합니다. 계약에 따라 Suzano가 51% 지분을 보유하고 KMB는 49%를 유지하며, 이 합작법인에는 KMB의 International Family Care 및 Professional 사업부가 포함됩니다. 해당 사업부는 2024년에 33억 달러의 순매출을 기록했으며, 기업 가치는 34억 달러로 평가됩니다. 이 합작법인은 70개 이상의 국가에서 운영되며, 22개의 제조 시설과 9,000명의 직원을 보유하게 됩니다. 이번 거래를 통해 KMB는 성장성이 높은 개인 케어 부문에 집중할 수 있으며, 향후 매출의 약 3분의 2가 개인 케어 카테고리에서 발생할 것으로 예상됩니다. 거래는 2026년 중반에 완료될 예정이며, 첫 완전 회계연도에 조정 EPS 기준 0.30~0.40 달러 희석 효과가 예상됩니다. Suzano는 향후 KMB의 나머지 49% 지분을 매입할 수 있는 옵션을 보유하게 됩니다.
Kimberly-Clark (KMB) a annoncé un partenariat stratégique avec Suzano (SUZ) pour créer une entreprise internationale leader dans les produits tissue et professionnels. Selon l'accord, Suzano détiendra 51 % et KMB conservera 49 % de la nouvelle coentreprise, qui inclura les activités International Family Care et Professional de KMB. L'activité apportée a généré 3,3 milliards de dollars de ventes nettes en 2024, avec une valeur d'entreprise implicite de 3,4 milliards de dollars. La coentreprise opérera dans plus de 70 pays, avec 22 sites de production et 9 000 employés. Cet accord permettra à KMB de se concentrer sur des segments de soins personnels à plus forte croissance, avec environ deux tiers des revenus futurs provenant des catégories de soins personnels. La transaction devrait être finalisée à la mi-2026 et entraînera une dilution de 0,30 à 0,40 dollar du BPA ajusté la première année complète. Suzano disposera d'options futures pour acquérir les 49 % restants détenus par KMB.
Kimberly-Clark (KMB) hat eine strategische Partnerschaft mit Suzano (SUZ) angekündigt, um ein führendes internationales Unternehmen für Tissue- und professionelle Produkte zu schaffen. Gemäß der Vereinbarung wird Suzano 51 % und KMB 49 % an dem neuen Joint Venture halten, das KMBs International Family Care- und Professional-Geschäft umfasst. Das eingebrachte Geschäft erzielte im Jahr 2024 einen Nettoumsatz von 3,3 Mrd. USD bei einem implizierten Unternehmenswert von 3,4 Mrd. USD. Das Joint Venture wird in über 70 Ländern tätig sein, 22 Produktionsstätten umfassen und 9.000 Mitarbeiter beschäftigen. Der Deal ermöglicht es KMB, sich auf wachstumsstärkere Segmente der Körperpflege zu konzentrieren, wobei etwa zwei Drittel der zukünftigen Umsätze aus dem Bereich der Körperpflege stammen werden. Der Abschluss der Transaktion wird für Mitte 2026 erwartet und wirkt sich im ersten vollen Jahr mit einer Verwässerung des bereinigten Gewinns je Aktie (Adjusted EPS) von 0,30 bis 0,40 USD aus. Suzano erhält zukünftige Optionen zum Kauf der verbleibenden 49 % Beteiligung von KMB.
Positive
  • Strategic focus on higher-growth, higher-margin personal care segments
  • Improved business mix with approximately two-thirds of revenue from personal care categories
  • Immediate cash proceeds to be returned to shareholders through share repurchases
  • Reduced exposure to volatile input costs, potentially leading to more predictable margins
  • Creation of operational efficiencies through combined capabilities and infrastructure
Negative
  • Expected dilution of $0.30-0.40 to Adjusted EPS in first full year after closing
  • Loss of direct control over international tissue and professional business
  • Potential future complete exit from the business if Suzano exercises its purchase option
  • Transaction won't close until mid-2026, creating extended period of uncertainty

Insights

Kimberly-Clark's strategic partnership with Suzano reshapes its portfolio toward higher-margin businesses while monetizing international tissue operations.

This transaction represents a significant strategic pivot for Kimberly-Clark, effectively divesting majority control of its International Family Care and Professional business to focus on its higher-margin personal care portfolio. By contributing its IFP business (valued at approximately $3.4 billion) to this new venture with Suzano, KMB is executing a classic portfolio optimization strategy that shifts its business mix toward better-performing segments.

The structure as a 49/51 joint venture rather than a complete sale is particularly noteworthy. This approach allows Kimberly-Clark to immediately monetize a significant portion of IFP's value while maintaining upside exposure through its 49% stake. Meanwhile, Suzano gains controlling interest in a branded consumer business that complements its position as the world's largest fiber manufacturer.

The transaction solves several strategic challenges for KMB. First, it reduces exposure to volatile input costs that have pressured margins in the tissue business. Second, it sharpens focus on personal care categories that will now represent approximately two-thirds of company revenues. Third, it generates immediate cash proceeds that management has committed to returning to shareholders through buybacks.

While the deal is expected to be $0.30-0.40 dilutive to adjusted EPS in the first year post-closing, this reflects the mathematical impact of divesting revenue-generating assets. The structure includes a path for Suzano to eventually acquire KMB's remaining stake, suggesting this is a staged exit from the international tissue business rather than a permanent joint venture arrangement.

This transaction ultimately represents the most substantial action yet in KMB's "Powering Care" transformation strategy, allowing management to reallocate capital and organizational resources toward categories where they believe they have stronger competitive advantages.

Kimberly-Clark's partnership with Suzano unlocks immediate capital while strategically pivoting to higher-margin personal care business.

This transaction fundamentally reshapes Kimberly-Clark's financial profile by divesting majority control of a $3.3 billion revenue segment representing approximately 25-30% of its total business. The $3.4 billion enterprise value assigned to the IFP business implies a valuation multiple of roughly 1x sales, which appears reasonable given the mature nature of the tissue category.

The near-term dilution of $0.30-0.40 to adjusted EPS is significant but expected given the scale of the divested operations. Management's commitment to return the cash proceeds to shareholders through share repurchases will partially offset this dilution, though the net impact remains negative in year one.

From a margin perspective, this transaction should be accretive over time. By retaining higher-margin personal care businesses while divesting the more commodity-influenced tissue operations, KMB's consolidated operating margins should gradually improve. The retained business will also have reduced exposure to pulp price volatility, which has historically created earnings unpredictability.

The reclassification of IFP as discontinued operations beginning in Q2 will create some near-term financial reporting complexity, but will ultimately provide cleaner visibility into the performance of KMB's continuing operations.

The option structure allowing Suzano to eventually acquire KMB's remaining 49% stake suggests management views this as a strategic exit rather than a permanent partnership. This approach maximizes immediate proceeds while maintaining potential upside if the venture succeeds in capturing operational efficiencies.

Financially, this transaction represents a decisive portfolio reshaping that should improve KMB's growth profile, margin structure, and capital allocation flexibility over the medium term, despite the short-term earnings dilution.

Forms Strategic Partnership with Suzano That Will Create Preeminent International Tissue and Professional Products Company

Sharpens Kimberly-Clark's Focus on Higher Growth, Higher Margin Personal Care and North America Tissue and Professional Categories 

Clears Path to Capture Huge Opportunities Across Kimberly-Clark and Newly Formed Venture to Drive Significant Shareholder Returns

DALLAS and SÃO PAULO, June 5, 2025 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) ("Kimberly-Clark" or the "Company") today announced that it has entered into an agreement with Suzano (NYSE: SUZ) to form a strategic partnership, creating a preeminent international tissue and professional products company and sharpening Kimberly-Clark's focus on its higher growth, higher margin businesses. Kimberly-Clark will own a 49% interest in the new venture, which will include substantially all the assets of its International Family Care and Professional ("IFP") business, and Suzano will own 51%.

"This transaction is a powerful step forward in the transformation strategy we laid out last year," said Kimberly-Clark Chairman and Chief Executive Officer, Mike Hsu. "Following years of deliberate investments that have strengthened Kimberly-Clark and IFP, we are excited to expand our partnership with Suzano and focus Kimberly-Clark's portfolio on our higher growth, higher margin businesses. Together, this positions each business to move forward with clarity and seize the tremendous opportunities ahead. We are grateful to our global teams who have made this moment possible."

Jeff Melucci, Kimberly-Clark's Chief Strategy, Business Development and Administrative Officer, said, "Suzano is a leader in its field, whose deep industrial manufacturing and fiber expertise complement Kimberly-Clark's leading brands and world-class commercial capabilities. We look forward to working closely with Suzano to ensure a smooth transition to this exciting venture for IFP, our customers and other stakeholders to deliver on the promise inherent in the business."

Compelling Strategic and Financial Benefits

  • Creates a preeminent international tissue and professional products company with significant, new operational efficiency opportunities. Since standing up IFP as a separate business in 2024, Kimberly-Clark has enhanced its margins and improved market share momentum. Joining forces with Suzano will enable the business to capture its full potential. The parties' combined capabilities and infrastructure is expected to reduce total delivered product costs and supply both branded and private label offerings across markets to benefit consumers and customers.

  • Sharpens Kimberly-Clark's Powering Care focus on proprietary, right to win spaces that improve its growth trajectory. The transaction focuses Kimberly-Clark on its higher growth and higher margin business segments – North America and International Personal Care – and shifts its business mix towards its iconic, global brands. Upon completion of the transaction, approximately two-thirds of the Company's net revenues will come from personal care categories, improving its long-term growth trajectory, profitability and returns on investment.

  • Optimizes value and enables return of capital to shareholders. Through the venture, IFP is expected to create more value for shareholders than Kimberly-Clark could achieve running IFP on its own. Kimberly-Clark will receive meaningful upfront cash proceeds that it expects to return to shareholders through share repurchases following the close of the transaction.

  • Improves cost management. Following the completion of the transaction, Kimberly-Clark will reduce its exposure to more volatile input costs, enhancing its ability to deliver more predictable and consistent margins and profit growth over time.

"This transaction generates immediate returns and long-term shareholder value as we capture the upside from a stronger international tissue and professional franchise and accelerate growth and innovation at Kimberly-Clark," said Nelson Urdaneta, Kimberly-Clark's Chief Financial Officer. "As the largest fiber manufacturer in the world, Suzano has been an instrumental strategic partner in our efforts to build a more efficient and effective global supply chain. We look forward to strengthening that partnership in the years to come."

Transaction and Financial Details

Kimberly-Clark will contribute substantially all the assets of its IFP business to the venture, which encompasses sales in more than 70 countries, 22 manufacturing facilities and approximately 9,000 employees. IFP's more than 40 regional brands will be owned by the new entity and its five global brands, including Scott, Kleenex, Viva, WypAll and Kimberly-Clark Professional, will be licensed to the venture by Kimberly-Clark under a long-term agreement. Kimberly-Clark's interests in Mexico and its joint venture in South Korea are outside the scope of this transaction.

The business Kimberly-Clark is contributing to the venture generated approximately $3.3 billion of net sales in 2024.1 The transaction contemplates an implied current enterprise value for the business of approximately $3.4 billion, subject to certain purchase price adjustments at closing.

The Company noted that, upon closing, the transaction is expected to be approximately $0.30-0.40 dilutive to Adjusted Earnings Per Share2 in the first full year following close, including the Company's expectation to return the initial cash proceeds from the transaction, net of taxes and transaction costs, to shareholders through share repurchases.

The Company also noted its expectation to classify the IFP businesses included in the transaction as discontinued operations within its financial disclosures beginning with its second quarter earnings results. The Company currently anticipates reporting its second quarter and six months results by early August.

The transaction is not subject to any financing contingency.

At certain specified times and subject to certain conditions, Suzano will have the option to purchase Kimberly-Clark's remaining 49% ownership interest under an agreed valuation framework.

Timing and Approvals

The transaction is subject to the satisfaction of customary consultation requirements and closing conditions, including obtaining required regulatory approvals. The transaction has been unanimously approved by Kimberly-Clark's Board of Directors and is expected to close in mid-2026.

Advisors

Centerview Partners and Goldman Sachs are serving as financial advisors to Kimberly-Clark, and Kirkland & Ellis LLP and Baker McKenzie LLP are serving as legal counsel.

Freshfields LLP is serving as legal counsel to Suzano.

About Kimberly-Clark

Kimberly-Clark (NASDAQ: KMB) and its trusted brands are an indispensable part of life for people in more than 175 countries and territories. Fueled by ingenuity, creativity, and an understanding of people's most essential needs, we create products that help individuals experience more of what's important to them. Our portfolio of brands, including Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll, hold No. 1 or No. 2 share positions in approximately 70 countries. We use sustainable practices that support a healthy planet, build strong communities, and ensure our business thrives for decades to come. We are proud to be recognized as one of the World's Most Ethical Companies® by Ethisphere for the seventh year in a row and one of Fortune's Most Innovative Companies in America in 2024. To keep up with the latest news and to learn more about the company's more than 150-year history of innovation, visit the Kimberly-Clark website.

About Suzano

Suzano is the world's largest pulp supplier, a major paper and packaging producer in the Americas, and one of Brazil's biggest employers. Driven by a deep commitment to sustainability and innovation, Suzano produces responsibly-grown raw materials that are exported to more than 100 countries around the world, meeting the global demand for bio-based solutions. These are used to make everyday items that reach more than two billion people, including toilet paper and tissue, packaging, printing and writing paper, personal hygiene products, and textiles. Founded in Brazil over 100 years ago, today Suzano operates across Latin America, North America, Europe and Asia. The company's shares are listed on the B3 in São Paulo (SUZB3) and the New York Stock Exchange (SUZ). Learn more at: suzano.com.br/en

Forward-Looking Statements

This press release contains certain forward-looking statements concerning Kimberly-Clark and the proposed transaction with Suzano to acquire an interest in the IFP business. All statements other than statements of fact, including information concerning future results, are forward-looking statements. These forward-looking statements are generally identified by the words "plan," "anticipate," "believe," "estimate," "expect," "intend," "may," "could" or similar expressions. Such forward-looking statements include, but are not limited to, statements about the benefits of the proposed transaction, including anticipated future financial and operating results, Kimberly-Clark's and the joint venture entity's (the "JV") objectives, expectations and intentions, expectations regarding the JV's performance, and the expected timing of completion of the proposed transaction. There are several factors which could cause actual plans and results to differ materially from those expressed or implied in forward-looking statements. Such factors include, but are not limited to, the failure to satisfy any of the conditions to the proposed transaction on a timely basis or at all; the occurrence of events that may give rise to a right of one or both of the parties to terminate the definitive agreements; adverse effects on the market price of Kimberly-Clark's common stock and on Kimberly-Clark's operating results because of a failure to complete the proposed transaction in the anticipated timeframe or at all; negative effects of the pendency or consummation of the proposed transaction on the market price of Kimberly-Clark's common stock and on Kimberly-Clark's operating results; the risk of litigation or regulatory actions; the possibility that Kimberly-Clark may not fully realize the projected benefits of the proposed transaction within the expected timeframe or at all; business disruption during the pendency of or following the proposed transaction; diversion of management time from ongoing business operations due to the proposed transaction; the risk of any unexpected costs or expenses resulting from the proposed transaction; the risk that the proposed transaction and its announcement or Kimberly-Clark's strategy generally could have an adverse effect on the ability of Kimberly-Clark or the JV to retain customers and retain and hire key personnel and maintain relationships with customers, suppliers, employees, stockholders and other business relationships and on its operating results and business generally; the effects of developments related to tariffs and proposed increases in tariffs on imported goods and the impacts it may have on Kimberly-Clark's operations and financial results; and other risks and uncertainties detailed in Kimberly-Clark's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, including in the sections thereof captioned "Risk Factors" as well as in its subsequent reports on Form 8-K and Form 10-Q, all of which are filed with the SEC and available at www.sec.gov and www.kimberly-clark.com. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause actual results to differ materially from those expressed in or implied by such forward-looking statements. Given these risks and uncertainties, persons reading this communication are cautioned not to place undue reliance on such forward-looking statements. Kimberly-Clark assumes no obligation to update or revise the information contained in this communication (whether as a result of new information, future events or otherwise), except as required by applicable law. References to our and the SEC's website are inactive textual references only. Information contained on our and the SEC's website is not incorporated by reference in this communication and should not be considered to be a part of this communication.

[KMB-F] [KMB-C]

_______________________________

1

The geographic distribution of net sales is approximately 33% Europe (ex UK), Middle East & Africa; 21% UK; 19%
Latin America; 16% Asia; and 11% Australia & New Zealand


2

Refer to our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q for information on this
non-GAAP measure. The Company does not provide a reconciliation of this forward-looking non-GAAP financial
measure to the most directly comparable GAAP financial measure on a forward-looking basis because it is unable
to predict certain adjustment items without unreasonable effort.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kimberly-clark-announces-major-step-forward-in-its-powering-care-transformation-302474231.html

SOURCE Kimberly-Clark Corporation

FAQ

What is the ownership structure of the new Kimberly-Clark and Suzano joint venture?

Suzano will own 51% of the joint venture, while Kimberly-Clark will retain a 49% ownership stake.

How much revenue did KMB's International Family Care and Professional business generate in 2024?

The business contributed to the venture generated approximately $3.3 billion in net sales in 2024.

What is the enterprise value of the KMB business being contributed to the joint venture?

The transaction implies a current enterprise value of approximately $3.4 billion for the contributed business.

How will this deal affect Kimberly-Clark's earnings per share?

The transaction is expected to be approximately $0.30-0.40 dilutive to Adjusted Earnings Per Share in the first full year following close.

When is the Kimberly-Clark and Suzano joint venture expected to close?

The transaction is expected to close in mid-2026, subject to regulatory approvals and customary closing conditions.

What assets are included in the Kimberly-Clark and Suzano joint venture?

The venture includes operations in over 70 countries, 22 manufacturing facilities, approximately 9,000 employees, and more than 40 regional brands, with five global brands licensed to the venture.
Suzano S.A.

NYSE:SUZ

SUZ Rankings

SUZ Latest News

SUZ Stock Data

11.05B
1.22B
4.51%
0.54%
Paper & Paper Products
Basic Materials
Link
Brazil
Salvador